Additionally, studies suggest that combining exosomal RNA and circulating tumor DNA (ctDNA) can increase the sensitivity of detecting EGFR mutations in the plasma of NSCLC patients, particularly when ctDNA levels are low81. Here, EGFR is linked to non-small cell lung carcinoma.